Cell and Gene Therapy Insights Volume 11 Issue 3

Volume 11 Issue 3

Download PDF

Featuring

Issue Spotlight: Gene therapy analytics and CMC
Other articles
Webinars

Gene therapy analytics and CMC

Expert Insight

A structured approach to addressing leachable risk in cell and gene therapies

Jason Creasey

24 April 2025

Read

Innovator Insight

Salt-tolerant endonucleases, the benefits for viral vector manufacturing and a comparison of two marketed enzymes

Marc Struhalla, Svenja Michalek

26 March 2025

Read

Viewpoint

A path toward universal agreement on fulfilling the need for rapid and reliable sterility assays in gene therapy

Qin Xiang

14 April 2025

Read

Interview

Harnessing AI and omics for next-generation gene therapy manufacturing

Richard Braatz, Irene Rombel

14 April 2025

Read

Advancing quality standards for gene therapies: a USP perspective

Fouad Atouf

8 April 2025

Read

articles

FastFacts

Essential equipment for advancing cell and gene therapy: innovations in incubation, monitoring, and cold storage

Tia Harmon

7 May 2025

Read

A novel PCR-free hybridization method for titering gene therapy vectors in crude cell lysates and various in-process matrices

Wai Choi

4 April 2025

Read

Interview

Overcoming translational challenges to advance cell therapy for neonatal brain injury

Mikey Creane

6 May 2025

Read

Exploring translational challenges and strategies for advancing gene therapies in neurodegenerative diseases

Joseph Scarrott

17 April 2025

Read

Exploring the challenges and innovations in CGT product commercialization

Ted Slocomb

14 April 2025

Read

Advancing optogenetic therapies for retinal diseases: a regulatory vision

Ananta Ayyagari

24 March 2025

Read

AAV capsid analysis and quantification with chromatography and ultracentrifugation-based techniques

Andreja Livk, Sebastijan Peljhan

27 February 2025

Watch

Cost reduction of viral vector processes using 3D nanofiber-based cell culture systems in upstream bioprocessing

R Noel, G Hamblen, C Fenge

1 April 2025

Watch

Strategies for streamlined manufacturing and analytics in CGT development

L Mueller, S Weber, D Windgassen

1 April 2025

Watch

Transforming viral vector manufacturing with next-generation CGMP plasmids platform

John Bowen, Brian Tomkowicz

2 April 2025

Watch

Armor CAR T cells with enhanced potency for cancer immunotherapy

Saba Ghassemi

8 April 2025

Watch

Moving AAV gene therapy beyond rare disease to address large patient populations with chronic disease

Dan Oliver, Ji Hyun Lee

9 April 2025

Watch

Achieving high-titer rAAV production with significantly reduced encapsidated host cell DNA

Ines Goncalves

10 April 2025

Watch

Next-generation sequencing in adventitious agent testing: navigating regulatory acceptance

Olaf Stamm, Horst Ruppach

15 April 2025

Watch

Manufacturing Quality Control for Plasmid DNA Critical Starting Materials

A Frazer, L R. Salvitti, S Lovatt et al.

29 April 2025

Watch

Safety assays for quality control of ATMPs: improved mycoplasma detection for cell-based biotherapeutics

Jens Björkman, Andreas Hecker

30 April 2025

Watch

Making robust choices: evaluating materials in your AAV process

Michael Bodo, Birgit Rogell

18 June 2025

Watch

CELL AND GENE THERAPY INSIGHTS

April 2025 Issue

Volume 11 Issue 3

Featuring

SPOTLIGHT

Gene therapy analytics and CMC

Expert Insight

A structured approach to addressing leachable risk in cell and gene therapies

Innovator Insight

Salt-tolerant endonucleases, the benefits for viral vector manufacturing and a comparison of two marketed enzymes

Viewpoint

A path toward universal agreement on fulfilling the need for rapid and reliable sterility assays in gene therapy

Interview

Harnessing AI and omics for next-generation gene therapy manufacturing

Advancing quality standards for gene therapies: a USP perspective

articles

FastFacts

Essential equipment for advancing cell and gene therapy: innovations in incubation, monitoring, and cold storage

A novel PCR-free hybridization method for titering gene therapy vectors in crude cell lysates and various in-process matrices

Interview

Overcoming translational challenges to advance cell therapy for neonatal brain injury

Exploring translational challenges and strategies for advancing gene therapies in neurodegenerative diseases

Exploring the challenges and innovations in CGT product commercialization

Advancing optogenetic therapies for retinal diseases: a regulatory vision

Webinars

AAV capsid analysis and quantification with chromatography and ultracentrifugation-based techniques

Cost reduction of viral vector processes using 3D nanofiber-based cell culture systems in upstream bioprocessing

Strategies for streamlined manufacturing and analytics in CGT development

Transforming viral vector manufacturing with next-generation CGMP plasmids platform

Armor CAR T cells with enhanced potency for cancer immunotherapy

Moving AAV gene therapy beyond rare disease to address large patient populations with chronic disease

Achieving high-titer rAAV production with significantly reduced encapsidated host cell DNA

Next-generation sequencing in adventitious agent testing: navigating regulatory acceptance

Manufacturing Quality Control for Plasmid DNA Critical Starting Materials

Safety assays for quality control of ATMPs: improved mycoplasma detection for cell-based biotherapeutics

Making robust choices: evaluating materials in your AAV process

CELL AND GENE THERAPY INSIGHTS

April 2025 Issue

Volume 11 Issue 3

Featuring

SPOTLIGHT

Gene therapy analytics and CMC

Expert Insight

A structured approach to addressing leachable risk in cell and gene therapies

Innovator Insight

Salt-tolerant endonucleases, the benefits for viral vector manufacturing and a comparison of two marketed enzymes

Viewpoint

A path toward universal agreement on fulfilling the need for rapid and reliable sterility assays in gene therapy

Interview

Harnessing AI and omics for next-generation gene therapy manufacturing

Advancing quality standards for gene therapies: a USP perspective

articles

FastFacts

Essential equipment for advancing cell and gene therapy: innovations in incubation, monitoring, and cold storage

A novel PCR-free hybridization method for titering gene therapy vectors in crude cell lysates and various in-process matrices

Interview

Overcoming translational challenges to advance cell therapy for neonatal brain injury

Exploring translational challenges and strategies for advancing gene therapies in neurodegenerative diseases

Exploring the challenges and innovations in CGT product commercialization

Advancing optogenetic therapies for retinal diseases: a regulatory vision

Webinars

AAV capsid analysis and quantification with chromatography and ultracentrifugation-based techniques

Cost reduction of viral vector processes using 3D nanofiber-based cell culture systems in upstream bioprocessing

Strategies for streamlined manufacturing and analytics in CGT development

Transforming viral vector manufacturing with next-generation CGMP plasmids platform

Armor CAR T cells with enhanced potency for cancer immunotherapy

Moving AAV gene therapy beyond rare disease to address large patient populations with chronic disease

Achieving high-titer rAAV production with significantly reduced encapsidated host cell DNA

Next-generation sequencing in adventitious agent testing: ﻿navigating regulatory acceptance

Manufacturing Quality Control for Plasmid DNA Critical Starting Materials

Safety assays for quality control of ATMPs: improved mycoplasma detection for cell-based biotherapeutics

Making robust choices: evaluating materials in your AAV process

Next-generation sequencing in adventitious agent testing: navigating regulatory acceptance